Asymptomatic Carriage Rate, Multidrug Resistance Level, and Associated Risk Factors of Enterococcus in Clinical Samples among HIV-Positive Patients Attending at Debre Birhan Comprehensive Specialized Hospital, North Showa, Ethiopia

Table 4

Bivariate analysis of associated factors for acquiring enterococcal infections at the Debre Birhan comprehensive hospital, May to August, 2021.

Characteristics	Total no. (%)	Enterococcal infection		COR (95% CI)	value
		Presence no. (%)	Absence no. (%)
Total	384 (100%)	34 (8.85%)	360 (91.15%)
Sex
Female	185 (48.8)	19 (10.4)	166 (89.6)	Ref
Male	199 (51.2)	15 (7.4)	184 (92.6)	2.19 (0.59-3.98)	0.91
Age
<5	19 (4.9)	3 (15.8)	11 (84.2)	0.93 (0.41-2.99)	0.55
5-15	59 (15.4)	5 (8.5)	54 (91.5)	0.88 (0.08-1.65)	0.52
16-30	105 (27.3)	10 (9.5)	95 (90.)5	0.36 (0.08-0.96)	0.51
31-50	123 (32)	9 (7.3)	114 (92.7)	1.23 (1.1-2.96)	0.09
>50	78 (20.3)	7 (8.97)	71 (91.03)	Ref
Hospital stays (hours)
<48	340	15 (4.6)	325 (95.4)	Ref
48+	44	19 (43.2)	25 (56.8)	6 (4.32-25.6)	0.025
CD4 count
<350	155 (40.4)	18 (11.6)	137 (88.4)	3.6 (2.1-9.76)	0.002
>350	229 (59.6)	16 (7.0)	213 (9.03)	Ref
WHO stage
I	165	4 (2.4)	161 (97.6)	Ref
II	95	8 (8.4)	87 (91.6)	0.5 (0.00-25.1)	1.00
III	93	13 (14.0)	80 (86.0)	0.65 (0.00-3.71)	0.56
IV	31	9 (29.0)	22 (71)	1.85 (1.33-3.71)	0.006
History
Antibiotics usage	84	7 (25.93)	77 (74.07)	Ref
Animal contact	111	8 (9)	103 (90)	1.74 (0.73–4.58)	0.15
Cancer	13	2 (33.33)	11 (66.67)	7.80 (0.00–116.25)	0.18
Catheterization	47	9 (64.7)	38 (35.3)	8.5 (5.12-44.31)	0.001
Diabetics	39	2 (0.00)	37 (100)	4.5 (0.00-19.28)	1.00
UTI	90	6 (3.64)	84 (96.36)	0.53 (0.08-2.42)	0.55